help@domespharma.com +44 (0) 800 038 5868

Remend® BioHAnce™ Corneal Gel for dogs, cats and horses to aid in the management of superficial corneal ulcers.

The main component in Remend® is cross-linked hyaluronic acid (HA).

Cross-linked HA has been shown to assist the healing process, and accelerate healing times in superficial corneal ulcers1, making Remend® BioHAnce™ Corneal Gel a valuable aid in the management of superficial corneal ulcers in dogs, cats and horses.

Remend® BioHAnce™ Technology: Patented Cross-Linked Hyaluronic Acid

  • Aid healing of ocular injuries in pets including, ulcers and trauma

  • Unique molecular matrix that protects and hydrates

  • Enhanced corneal retention time offers lasting benefits2,3

  • Aid compliance with just 1 drop twice daily

  • Packs of 10 x 3ml dropper bottle – 10-14 days of administration

  • Convenient and easy to use

 

 

Remend® BioHAnce™ Corneal Gel does not contain an antibiotic; where antimicrobial treatment is required, appropriate therapy should be initiated.
1. Yang G,Espandar L, Mamalis N, Prestwich GD. A cross-linked hyaluronan gel accelerates healing of corneal epithelial abrasion and alkali burn injuriesin rabbits. Vet Ophthalmol. 2010;13(3) :144–150. 2. Plummer, C.E., et al. Evaluation of Topically Applied Cross-linked Hyaluronic Acid (Remend®) on the Ocular Surface of Clinically Healthy Dogs. ACVO 2022 Conference Proceedings, Pg 130. 3. F Montiani-Ferreira et al. Fluorometric evaluation of cross-linked vs linear hyaluronic acid eye lubricants, ACVO 2022 Conference Proceedings, Pg 170.